BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 23182298)

  • 1. Antibody-mediated vascular rejection of kidney allografts: a population-based study.
    Lefaucheur C; Loupy A; Vernerey D; Duong-Van-Huyen JP; Suberbielle C; Anglicheau D; Vérine J; Beuscart T; Nochy D; Bruneval P; Charron D; Delahousse M; Empana JP; Hill GS; Glotz D; Legendre C; Jouven X
    Lancet; 2013 Jan; 381(9863):313-9. PubMed ID: 23182298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-Mediated Acute Vascular Rejection of Kidney Allografts: Fifteen-Year Follow-up.
    Rodríguez Cubillo B; Pérez Flores I; Calvo N; Pascual A; Cortés JA; Moreno MA; Blanco J; Sánchez Fructuoso A
    Transplant Proc; 2016 Nov; 48(9):2917-2919. PubMed ID: 27932107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and pathological analyses of chronic vascular rejection after kidney transplantation.
    Shimizu T; Toma H; Shibahara R; Tsunoyama K; Izuka J; Nozaki T; Ishida H; Tanabe K; Honda K; Koike J
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():20-5. PubMed ID: 26031581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-binding anti-HLA antibodies and kidney-allograft survival.
    Loupy A; Lefaucheur C; Vernerey D; Prugger C; Duong van Huyen JP; Mooney N; Suberbielle C; Frémeaux-Bacchi V; Méjean A; Desgrandchamps F; Anglicheau D; Nochy D; Charron D; Empana JP; Delahousse M; Legendre C; Glotz D; Hill GS; Zeevi A; Jouven X
    N Engl J Med; 2013 Sep; 369(13):1215-26. PubMed ID: 24066742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression patterns of B cells in acute kidney transplant rejection.
    Carpio VN; Noronha Ide L; Martins HL; Jobim LF; Gil BC; Külzer AS; Loreto Mda S; Gonçalves LF; Manfro RC; Veronese FV
    Exp Clin Transplant; 2014 Oct; 12(5):405-14. PubMed ID: 25299368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated rejection.
    Akalin E; Watschinger B
    Semin Nephrol; 2007 Jul; 27(4):393-407. PubMed ID: 17616272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
    Crespo M; Torio A; Mas V; Redondo D; Pérez-Sáez MJ; Mir M; Faura A; Guerra R; Montes-Ares O; Checa MD; Pascual J
    Transpl Immunol; 2013 Dec; 29(1-4):28-33. PubMed ID: 23907088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
    Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2718-20. PubMed ID: 18021967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
    Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The histopathology of lung allograft dysfunction associated with the development of donor-specific HLA alloantibodies.
    Yousem SA; Zeevi A
    Am J Surg Pathol; 2012 Jul; 36(7):987-92. PubMed ID: 22510758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Putative antibody-mediated rejection with C4d deposition in HLA-identical, ABO-compatible renal allografts.
    Collins AB; Chicano SL; Cornell LD; Tolkoff-Rubin N; Goes NB; Saidman SL; Farrell ML; Cosimi AB; Colvin RB
    Transplant Proc; 2006 Dec; 38(10):3427-9. PubMed ID: 17175293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
    Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
    J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
    Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection.
    Sis B; Halloran PF
    Curr Opin Organ Transplant; 2010 Feb; 15(1):42-8. PubMed ID: 20009933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical and molecular significance of C4d staining patterns in renal allografts.
    Hayde N; Bao Y; Pullman J; Ye B; Calder BR; Chung M; Schwartz D; Alansari A; de Boccardo G; Ling M; Akalin E
    Transplantation; 2013 Feb; 95(4):580-8. PubMed ID: 23274969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood group Lewis alloantibodies cause antibody-mediated rejection in renal transplant recipients.
    Boratyńska M; Banasik M; Hałoń A; Patrzałek D; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2711-4. PubMed ID: 18021965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period.
    Sánchez-Zapardiel E; Castro-Panete MJ; Castillo-Rama M; Morales P; Lora-Pablos D; Valero-Hervás D; Ruiz-García R; Apaza J; Talayero P; Andrés A; Morales JM; Paz-Artal E
    Transplantation; 2013 Jul; 96(1):70-8. PubMed ID: 23624543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genes associated with antibody-dependent cell activation are overexpressed in renal biopsies from patients with antibody-mediated rejection.
    Suviolahti E; Ge S; Nast CC; Mirocha J; Karasyov A; White M; Jordan SC; Toyoda M
    Transpl Immunol; 2015 Jan; 32(1):9-17. PubMed ID: 25449536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic analysis of acute vascular rejection cases after renal transplantation.
    Shimizu T; Tanabe T; Omoto K; Ishida H; Tanabe K
    Transplant Proc; 2012 Jan; 44(1):230-5. PubMed ID: 22310621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.